Vimarsana
Biggest News Aggregation in the World

Page 29 - Program Updates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Program Updates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Program Updates Today - Breaking & Trending Today

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces R&D Day Agenda - Vimarsana News

Investegate |atai Life Sciences Announcements | atai Life Sciences: atai Life Sciences Announces R&D Day Agenda

Investegate announcements from atai Life Sciences, atai Life Sciences Announces R&D Day Agenda

Daher Weaves Sustainability Into Kodiak 900 and TBM 960 - Vimarsana News

Daher Weaves Sustainability Into Kodiak 900 and TBM 960

The turboprop line now flies out of the factory on sustainable aviation fuel, with eco-challenge features incorporated into the Me & My TBM app.

Unicycive Announces Second Quarter Financial Results and Provides Business Update - Vimarsana News

Unicycive Announces Second Quarter Financial Results and Provides Business Update

16.08.2022 - On track to file New Drug Application for Renazorb, the first proprietary nanoparticle-based phosphate binder for Chronic Kidney Disease (CKD) patients, by end of 2023 Signed first global partnership for rights to Renazorb in China with Lee’s ...

IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update

Strong balance sheet of ~$324 million cash, cash equivalents and marketable securities as of June 30, 2022 is anticipated to fund planned operatio...

Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2022 - Vimarsana News

Poseida Therapeutics Provides Updates and Financial Results for the Second Quarter of 2022

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...